Global Left Atrial Appendage (LAA) Closure Market 2016-2020

Global Left Atrial Appendage (LAA) Closure Market 2016-2020

Category : Healthcare
Published On : December  2015
Pages : 57



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
Market outlook of the left atrial appendage closure market
The left atrial appendage (LAA) is a small ear-shaped sac in the muscle wall of the top left chamber of the heart that controls the electrical impulses during atrial fibrillation. LAA closure device is an interventional device used to prevent stroke, reduce the risk of secondary stroke and emboli because of atrial fibrillation. The global left atrial appendage closure market is expected to grow at a massive CAGR of over 28% during the forecast period.

Numerous factors drive the left atrial appendage closure market, but one of the main factors is the significant increase in the incidences of stroke. It is estimated that around 15 million people suffer a stroke every year across the globe. With the rise in the aging population, excessive smoking, average hypertension, and cholesterol levels, the number of atrial fibrillation cases is also increasing globally.

Segmentation by product and analysis of - epicardial LAA closure and endocardial LAA closure
The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -

• Epicardial LAA closure device
• Endocardial LAA closure device

Endocardial involves implantation of a device to occlude the LAA. Endocardial LAA closure devices are implanted through a transseptal approach under TEE technique. A specific delivery system has been developed for each device type allowing for repositioning, collapse, or removal in the event of suboptimal results.

Geographical segmentation and analysis of - Americas, APAC, EMEA
The EMEA region is the highest revenue generator in the left atrial appendage closure market in 2015, accounting for about 52% share, and then followed by the APAC region. The market in the EMEA is expected to continue its growth during the forecast period and this is attributed to increase in the incidence of strokes and the growing elderly population. Stroke alone accounts for 1.1 million deaths in Europe every year.

The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -

• Americas
• APAC
• EMEA

Competitive landscape and key vendors - AtriCure, Boston Scientific, St. Jude, Coherex Medical
The LAA closure market witness the presence of very few market vendors, hence the competition in the market is moderate at present. However, the competition is expected to intensify with new product launches. Also, there is a vast opportunity for the market to grow significantly in the Americas in the forecast period.

Primary vendors in this market are:
• AtriCure
• Boston Scientific
• St. Jude
• Coherex Medical

Other prominent vendors included in this report are Lifetech Scientific, SentreHEART, and Occlutech.

Key questions answered in the report include
• What will the market size and the growth rate be in 2019?
• What are the key factors driving the global left atrial appendage closure market?
• What are the key market trends impacting the growth of the global left atrial appendage closure market?
• What are the challenges to market growth?
• Who are the key vendors in the global left atrial appendage closure market?
• What are the market opportunities and threats faced by the vendors in the global left atrial appendage closure market?
• What are the trending factors influencing the market shares of the APAC, EMEA, and the Americas?
• What are the key outcomes of the five forces analysis of the global left atrial appendage closure market?
• Technavio also offers customization on reports based on specific client requirement.

Related reports
• Global Atrial Fibrillation Market 2015-2019
• Global Coronary Artery Disease Treatment Devices Market 2015-2019
• Global Geriatric Care Devices Market 2015-2019
• Brain Monitoring Devices - Global Market Research 2015-2019
• Global Heart Defect Closure Devices Market 2014-2018
PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 06: Pipeline analysis

PART 07: Regulation of LAA closure devices

PART 08: Market segmentation by product

PART 09: Geographical segmentation
Left atrial appendage closure market in Americas
Left atrial appendage closure market in EMEA
Left atrial appendage closure market in APAC

PART 10: Market drivers
Increasing incidences of stroke
Potential long-term cost-effectiveness of LAA closure devices
Rise in aging population

PART 11: Impact of drivers

PART 12: Market challenges
Complicated LAA closure implantation procedure
Stringent regulation for approval of device and product recalls
High acceptance of warfarin and dabigatran

PART 13: Impact of drivers and challenges

PART 14: Market trends
Focus on clinical trials
Increase in awareness programs
Significant growth in US

PART 15: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors

PART 16: Key vendor analysis
AtriCure
Boston Scientific
St. Jude
Coherex Medical

PART 17: Appendix
List of abbreviations

PART 18: Explore Technavio

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global left atrial appendage closure market 2015-2020 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Pipeline analysis snapshot of LAA closure device
Exhibit 05: Snapshot for regulation of medical devices
Exhibit 06: Timeline of key events - Watchman device regulations
Exhibit 07: Segmentation of LAA closure by product
Exhibit 08: Segmentation of global left atrial appendage closure market by geography 2015
Exhibit 09: Segmentation of global left atrial appendage closure market by geography 2020
Exhibit 10: Segmentation of global left atrial appendage closure market by geography 2015-2020
Exhibit 11: Left atrial appendage closure market in Americas 2015-2020 ($ millions)
Exhibit 12: Left atrial appendage closure market in EMEA 2015-2020 ($ millions)
Exhibit 13: Left atrial appendage closure market in APAC 2015-2020 ($ millions)
Exhibit 14: Impact of drivers
Exhibit 15: Impact of drivers and challenges
Exhibit 16: Key takeaways: Boston Scientific
Exhibit 17: Key takeaways: St. Jude Medical
Exhibit 18: Key takeaways: AtriCure
Exhibit 19: Key takeaways: Coherex Medical
Exhibit 20: AtriCure: Product categories
Exhibit 21: AtriCure: Geographical segmentation by revenue 2014
Exhibit 22: Boston Scientific: Business segmentation by revenue 2014
Exhibit 23: Boston Scientific: Business segmentation by revenue 2013 and 2014
Exhibit 24: St. Jude: Product segmentation by revenue 2014
Exhibit 25: St. Jude: Product segmentation by revenue 2013 and 2014
Exhibit 26: Coherex Medical: Product offering

Enquiry Before Buy